Vimarsana
Biggest News Aggregation in the World

Omicron Xbb News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Omicron Xbb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Omicron Xbb Today - Breaking & Trending Today

Sama condemns 'misinformation' about Covid-19 Omicron XBB variant - Vimarsana News

Sama condemns 'misinformation' about Covid-19 Omicron XBB variant

The South African Medical Association (Sama) has condemned the spread of misinformation on social media platforms about the Covid-19 Omicron XBB variant.

Omicron's XBB Most Prevalent Variant Across India: Centre's Research Body - Vimarsana News

Omicron's XBB Most Prevalent Variant Across India: Centre's Research Body

COVID-19 variant Omicron and its sub-lineages continue to be the dominant variant in India with 'XBB' being the most prevalent sub-lineage circulating all over the country, the INSACOG said in its bulletin.

Source: ndtv.com
Covid-19 alert: This new coronavirus variant is causing most infections in India, know symptoms - Vimarsana News

Covid-19 alert: This new coronavirus variant is causing most infections in India, know symptoms

Omicron BF.7 cases, a new variation of Corona that originated in China, have been reported in India. India continues to be dominated by Omicron XBB.

Omicron BF.7, XBB and other Covid variants are circulating in India. Check key symptoms here - Vimarsana News

Omicron BF.7, XBB and other Covid variants are circulating in India. Check key symptoms here

Over 500 omicron variants are currently circulating worldwide and we are likely to see move Covid wave in the coming days

New COVID 'Variant of Concern' XBB May Lack Surge Potential - Vimarsana News

New COVID 'Variant of Concern' XBB May Lack Surge Potential

XBB has been on the CDC’s radar since earlier this month, when it first began doubling its case counts every 12 days. It is a combination of two Omicron subvariants (BA.2.10.1 and BA.2.75) first seen in September and is among a growing group that could render some antibody treatments ineffective.

Source: webmd.com